The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Schering-Plough to pay $435 million, pleads guilty to charge of selling drugs for unapproved uses, overcharging Medicaid
The company has just agreed to pay a
massive settlement for unapproved marketing and sales
. -AMS
pharmamanufacturing
Aug. 30, 2006
The company has just agreed to pay a
massive settlement for unapproved marketing and sales
. -AMS
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
UK pharmaceuticals exempt from tariffs in US drug pricing agreement
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Novo Nordisk gets Form 483 from FDA after inspection at Plainsboro, NJ site
Lonza divests capsules and health ingredients business for $2.2B in upfront cash
Drugmakers and CDMOs seize GLP-1 opportunity, invest in manufacturing facilities
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content